Cargando…

Comments regarding use of rifabutin for Helicobacter pylori eradication

Detalles Bibliográficos
Autor principal:	Graham, David Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504271/ https://www.ncbi.nlm.nih.gov/pubmed/34646357 http://dx.doi.org/10.1177/17562848211044064

Ejemplares similares

Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Düzenli, Tolga, et al.
Publicado: (2023)

Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial
por: Kalfus, Ira N., et al.
Publicado: (2020)

Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties
por: Borraccino, Antonia Valeria, et al.
Publicado: (2022)

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
por: Navarro-Jarabo, José M, et al.
Publicado: (2007)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Sue, Soichiro, et al.
Publicado: (2018)

Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2018)

“Latent Gastric Cancer” after Eradicating Helicobacter pylori
por: Uno, Yoshiharu
Publicado: (2018)

Helicobacter pylori eradication: the relevance of a periodic update
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Response to Treatment of Helicobacter pylori-associated Dyspepsia: Eradication of Helicobacter pylori or Correction of Gastric or Intestinal Dysbiosis?
por: Abraham, Philip, et al.
Publicado: (2018)

Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
por: Gisbert, Javier P.
Publicado: (2020)

Role of concomitant therapy for Helicobacter pylori eradication: A technical note
por: Losurdo, Giuseppe, et al.
Publicado: (2016)

RE: Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

Considering the Long-Conflicting Topic of Empirical or Nonconventional Helicobacter pylori Eradication Regimens
por: Kountouras, Jannis
Publicado: (2023)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Amoxycillin and Metronidazole Therapy for Helicobacter pylori Eradication: A 10-Year Trend in Turin, Italy
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2017)

Gastrin drives gastric cancer due to oxyntic atrophy also after Helicobacter pylori eradication
por: Waldum, Helge
Publicado: (2020)

Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit–risk approach?
por: Sitkin, Stanislav, et al.
Publicado: (2022)

Response to: Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2016)

Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen
por: Inokuchi, Kazumi, et al.
Publicado: (2022)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Surveillance strategies for precancerous gastric conditions after Helicobacter pylori eradication: There is still need for a tailored approach
por: Shahini, Endrit, et al.
Publicado: (2021)

Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2017)

Comment on “Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics”
por: Kazakos, Evangelos I, et al.
Publicado: (2017)

The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders
por: Kountouras, Jannis, et al.
Publicado: (2019)

Statistical proof of Helicobacter pylori eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
por: Kuo, Chia-Jung, et al.
Publicado: (2020)

Comment “Asymptomatic small intestinal ulcerative lesions: Obesity and Helicobacter pylori are likely to be risk factors”
por: Wang, Wei, et al.
Publicado: (2022)

Recurrent neutropenia induced by rifabutin in a renal transplant recipient
por: Chang, Ji Yeun, et al.
Publicado: (2014)

Response to “Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial”
por: Patil, Anant D
Publicado: (2018)

Clinical significance of genetic polymorphisms of interleukin-1β and cytochrome P450 2C19 on the eradication of Helicobacter pylori
por: Karbalaei, Mohsen, et al.
Publicado: (2023)

Helicobacter pylori and Immunocompromised Children
por: Nutpho, Prakaimuk, et al.
Publicado: (2006)

Helicobacter pylori, Republic of Georgia
por: Kretsinger, Katrina, et al.
Publicado: (2005)

Hepatitis C and Helicobacter Pylori
por: Wiwanitkit, Viroj
Publicado: (2010)

Helicobacter pylori Infection and Anemia
por: Muhsen, Khitam, et al.
Publicado: (2013)

Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015)

Helicobacter Pylori: Indian perspective
por: Patnayak, Rashmi, et al.
Publicado: (2015)

Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis - Reply
por: Mesquita, Priscila Miranda Diogo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_63v91lviu9r5sghsuvb8e6k9lo